文献速递临床试验与 GCP医学人工智能与信息学基础与转化研究

基于自适应人工智能的虚拟现实运动系统用于超重青少年:一项随机对照试验

An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial.
PubMed 文献 · Nat Med · 2025-06-23

研究开发了基于深度强化学习训练虚拟教练的REVERIE虚拟现实运动系统,并纳入227名超重青少年开展为期8周的随机对照试验,按1:1:1:1:1分为实体乒乓球、实体足球、REVERIE乒乓球、REVERIE足球和对照组。REVERIE运动可降低主要结局脂肪质量(均值-4.28 kg,95%CI -6.35至-2.22,相对于对照),与实体运动相比无显著差异(均值-5.06 kg,95%CI -7.13至-2.98,相对于对照)。

要点

  • REVERIE虚拟现实运动使超重青少年脂肪质量较对照平均降低4.28 kg(95%CI -6.35至-2.22)。
  • 实体运动较对照平均降低脂肪质量5.06 kg(95%CI -7.13至-2.98),与REVERIE无显著差异。
  • REVERIE组最小损伤率为7.69%,实体运动组为13.48%,无严重不良事件。

核心结论

  • 虚拟现实运动疗法可为应对青少年肥胖提供共情式方法,在减重之外全面改善身体、心理和认知健康。

研究设计与样本

  • 研究开发了使用深度强化学习训练基于Transformer的虚拟教练智能体的REVERIE虚拟现实运动系统。
  • 随机对照试验纳入227名超重青少年,进行为期8周的干预。
  • 参与者按1:1:1:1:1随机分配至实体乒乓球、实体足球、REVERIE乒乓球、REVERIE足球或对照组。

主要发现

  • REVERIE运动较对照降低主要结局脂肪质量,均值-4.28 kg(95%CI -6.35至-2.22)。
  • 实体运动较对照降低脂肪质量,均值-5.06 kg(95%CI -7.13至-2.98);REVERIE运动与实体运动相比无显著差异。
  • 实体运动和REVERIE运动组较对照出现肝酶和低密度脂蛋白胆固醇水平下降。
  • 实体运动和REVERIE运动在8周干预后改善体适能、心理健康和运动意愿,REVERIE运动组在6个月随访时仍保持。
  • 探索性分析显示REVERIE运动较实体运动认知改善更优,嗅觉测试总分均值2.84(95%CI 1.15至4.53),工作记忆范式2-back正确率均值10.88%(95%CI 1.19%至20.56%)。

关键数值与推荐

  • 主要结局脂肪质量:REVERIE运动较对照均值-4.28 kg(95%CI -6.35至-2.22);实体运动较对照均值-5.06 kg(95%CI -7.13至-2.98)。
  • 探索性分析嗅觉测试总分:REVERIE运动较实体运动均值2.84(95%CI 1.15至4.53)。
  • 探索性分析工作记忆范式2-back正确率:REVERIE运动较实体运动均值10.88%(95%CI 1.19%至20.56%)。
  • 最小损伤率:REVERIE为7.69%,实体运动为13.48%,无严重不良事件。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adolescents with obesity face numerous health risks and encounter barriers that lead to physical inactivity. We developed a virtual reality sports system, named REVERIE (Real-World Exercise and VR-Based Exercise Research in Education), which used deep reinforcement learning to train transformer-based virtual coaching agents, offering immersive and effective sports guidance, with biomechanical performance comparable to real-world physical sports. We integrated REVERIE into a randomized controlled trial involving an 8-week intervention in adolescents with excess body weight (n = 227). Participants were randomized (1:1:1:1:1) to physical table tennis, physical soccer, REVERIE table tennis, REVERIE soccer or control. REVERIE sports intervention was effective in reducing primary outcome fat mass (mean -4.28 kg (95% confidence interval (CI) -6.35 to -2.22), relative to control), with no significant difference compared with physical sports (mean -5.06 kg (95% CI -7.13 to -2.98), relative to control). For secondary outcomes, decreases in liver enzymes and low-density lipoprotein cholesterol levels were found in physical and REVERIE sports groups compared to control. Physical and REVERIE sports showed improvements in physical fitness, psychological well-being and sports willingness after an 8-week intervention, which remained at the 6-month follow-up in the REVERIE sports group. REVERIE sports demonstrated superior cognitive enhancements compared to physical sports in exploratory analyses, as evidenced by olfactory tests (total score: mean 2.84 (95% CI 1.15 to 4.53)) and working memory paradigm (2-back accuracy: mean 10.88% (95% CI 1.19% to 20.56%)). Functional magnetic resonance imaging exhibited that REVERIE sports enhanced neural efficiency and neuroplasticity. Multi-omics analyses revealed distinct changes induced by REVERIE sports that were closely associated with cognitive improvement. Minimal injury rates were 7.69% for REVERIE and 13.48% for physical sports, with no serious adverse events. Collectively, this study demonstrates that the virtual reality sports therapy could provide an empathetic approach to addressing adolescent obesity, offering comprehensive improvements in physical, psychological and cognitive health beyond mere weight loss. Clinical Trial registration: ChiCTR2300068786 .

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Wang J, Qin Y, Wu Q, et al. An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial. Nat Med. 2025. PMID: 40551019. doi:10.1038/s41591-025-03724-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。